Format

Send to

Choose Destination
Best Pract Res Clin Rheumatol. 2014 Jun;28(3):353-66. doi: 10.1016/j.berh.2014.08.002. Epub 2014 Nov 18.

Burden of disability due to musculoskeletal (MSK) disorders.

Author information

1
University of Sydney Institute of Bone and Joint Research, and Royal North Shore Hospital, St Leonards, NSW, Australia.
2
University of Queensland, School of Population Health, Herston, QLD, Australia.
3
University of Sydney Institute of Bone and Joint Research, and Royal North Shore Hospital, St Leonards, NSW, Australia; Institut d'Investigacio Biomedica de Bellvitge, Hospital Universitari de Bellvitge, Departament de Reumatologia, L'Hospitalet de Llobregat, Barcelona, Spain.
4
School of Public Health, University of Sydney, Sydney, NSW, Australia.
5
Monash Department of Clinical Epidemiology, Cabrini Institute, Melbourne, VIC, Australia.
6
University of Queensland, School of Population Health, Herston, QLD, Australia; Institute of Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
7
Department of Rheumatology, Royal Cornwall Hospital, Truro, UK. Electronic address: woolf@btinternet.com.

Abstract

This chapter summarises the global and regional prevalence, disability (Years Lived with Disability (YLDs)) and overall burden (Disability Adjusted Life Years (DALYs)) and costs for the common musculoskeletal disorders including low back and neck pain, hip and knee osteoarthritis, rheumatoid arthritis, gout, and a remaining combined group of other MSK conditions. The contribution of the role of pain in disability burden is introduced. Trends over time and predictions of increasing MSK disability with demographic changes are addressed and the particular challenges facing the developing world are highlighted.

KEYWORDS:

Burden; Costs; DALYs; Developing countries; Global trends; MSK disorders; Pain; Prevalence; YLDs

PMID:
25481420
DOI:
10.1016/j.berh.2014.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center